Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab.
Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al.
Blood.
2020;
26:S138-S138.
Interferon-complement loop in transplant-associated thrombotic microangiopathy.
Jodele, S; Medvedovic, M; Luebbering, N; Chen, J; Dandoy, CE; Laskin, BL; Davies, SM.
Blood Advances.
2020;
4:1166-1177.
EASIX and mortality after allogeneic stem cell transplantation.
Luft, T; Benner, A; Terzer, T; Jodele, S; Dandoy, CE; Storb, R; Kordelas, L; Beelen, D; Gooley, T; Sandmaier, BM; et al.
Bone Marrow Transplantation.
2020;
55:553-561.
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Buchbinder, D; Brazauskas, R; Bo-Subait, K; Ballen, K; Parsons, S; Johns, T; Hahn, T; Sharma, A; Steinbergs, A; D'Souza, A; et al.
Biology of Blood and Marrow Transplantation.
2020;
26:553-561.
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.
Dandoy, CE; Kim, S; Chen, M; Ahn, KW; Ardura, MI; Brown, V; Chhabra, S; Diaz, MA; Dvorak, C; Farhadfar, N; et al.
JAMA Network Open.
2020;
3:e1918668-e1918668.
Improving the Timeliness of Chemotherapy Administration in the Bone Marrow Transplant Unit.
Bhandari, R; Orgel, E; Rushing, T; Malicse, K; Evangelista, V; Jodele, S; Dandoy, CE.
Biology of Blood and Marrow Transplantation.
2020;
26:150-156.
MBI-LCBI and CLABSI: more than scrubbing the line.
Dandoy, CE; Alonso, PB.
Bone Marrow Transplantation.
2019;
54:1932-1939.
Pediatric and Young Adult Vulvovaginal Graft-versus-Host Disease.
Cizek, SM; El-Bietar, J; Rubinstein, J; Dandoy, C; Wallace, GH; Nelson, A; Khandelwal, P; Myers, KC; Hoefgen, HR.
Biology of Blood and Marrow Transplantation.
2019;
25:2408-2415.
Outcomes after bloodstream infection in hospitalized pediatric hematology/oncology and stem cell transplant patients.
Dandoy, CE; Kelley, T; Gaur, AH; Nagarajan, R; Demmel, K; Alonso, PB; Guinipero, T; Savelli, S; Hakim, H; Owings, A; et al.
Pediatric Blood and Cancer.
2019;
66.
Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated with Increased Mortality after Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.
Papanicolaou, GA; Ustun, C; Young, JH; Chen, M; Kim, S; Ahn, KW; Komanduri, K; Lindemans, C; Auletta, JJ; Riches, ML; et al.
Clinical Infectious Diseases.
2019;
69:1771-1779.